RevBio, Inc.

medical devices

About

RevBio, Inc. is a clinical-stage medical device company based in Lowell, Massachusetts. The company specializes in TETRANITE®, a patented synthetic bone adhesive biomaterial that is injectable, self-setting, load-bearing, and osteoconductive. Inspired by the marine sandcastle worm, TETRANITE is designed to bond bone to bone and bone to metal, even in wet surgical environments. This innovative technology aims to enhance bone repair by providing rapid mechanical stability and controlled biodegradability. RevBio's product platform targets various clinical markets, including dental, cranial, trauma, spinal, and veterinary applications. The company plans to launch its first product, a veterinary dental bone adhesive, by the end of 2024, followed by human-use products for dental and cranial applications by mid-2026. RevBio operates from the Massachusetts Medical Device Development Center (M2D2) and collaborates with leading research institutions to develop products based on TETRANITE technology. The company has secured multiple patents for its innovations and has received significant funding to support its development efforts.

Technologies

Outlook Amazon AWS Hubspot Mobile Friendly WordPress.org Google Tag Manager reCAPTCHA Google Analytics Nginx Wordpress.com Gravity Forms Render Node.js Android Remote IoT AI Proofpoint

Keywords

biomaterials medical device dental biomimetics bone innovation bone graft orthopaedics oral surgery neurosurgery veterinary medicine trauma periodontics biologics therapeutics regenerative medicine adhesive musculoskeletal spine fracture repair medical devices medical health care medical equipment manufacturing biotechnology bioengineered bone adhesive extremity fracture fixation bioactive bone adhesive biomimetic bone adhesive bone adhesive mechanism

Location

600 Suffolk St, Lowell, Massachusetts, United States, 01854

Related Companies

Companies in the same industry